Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

The use of Resolor (prucalopride) for chronic constipation in women.

Woodward S.

Br J Nurs. 2012 Sep 13-26;21(16):982, 984-6.

PMID:
23123655
2.

Prucalopride for the treatment of women with chronic constipation in whom standard laxative regimens have failed to provide adequate relief.

Pennant M, Orlando R, Barton P, Bayliss S, Routh K, Meads C.

Health Technol Assess. 2011 May;15 Suppl 1:43-50. doi: 10.3310/hta15suppl1/05. Review.

3.

[Evaluation of the efficacy of prucalopride (resolor) in the treatment of patients with chronic constipation].

Osipenko MF, Bikbulatova EA, Skalinskaia MA, Kulygina IuA, Pankova LIu.

Ter Arkh. 2013;85(12):60-4. Russian.

PMID:
24640670
4.

Prucalopride: a review of its use in the management of chronic constipation.

Keating GM.

Drugs. 2013 Nov;73(17):1935-50. doi: 10.1007/s40265-013-0140-1. Review.

PMID:
24194435
5.

[Some practical questions on chronic stipsis treatment with prucalopride].

Bellacosa L, Cogliandro R, Cremon C, De Giorgio R, Barbara G, Stanghellini V.

Minerva Gastroenterol Dietol. 2014 Mar;60(1):85-99. Review. Italian.

PMID:
24632771
6.

Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives.

Tack J, van Outryve M, Beyens G, Kerstens R, Vandeplassche L.

Gut. 2009 Mar;58(3):357-65. doi: 10.1136/gut.2008.162404. Epub 2008 Nov 5. Erratum in: Gut. 2012 Sep;61(9):1298.

PMID:
18987031
7.

Effect of prucalopride on symptoms of chronic constipation.

Tack J, Stanghellini V, Dubois D, Joseph A, Vandeplassche L, Kerstens R.

Neurogastroenterol Motil. 2014 Jan;26(1):21-7. doi: 10.1111/nmo.12217. Epub 2013 Sep 20.

8.

Prucalopride: A Review in Chronic Idiopathic Constipation.

Garnock-Jones KP.

Drugs. 2016 Jan;76(1):99-110. doi: 10.1007/s40265-015-0518-3. Review.

PMID:
26628294
9.

What role for prucalopride in constipation?

[No authors listed]

Drug Ther Bull. 2011 Aug;49(8):93-6. doi: 10.1136/dtb.2011.02.0050. Review.

PMID:
21831905
10.

Prucalopride, a systemic enterokinetic, for the treatment of constipation.

Emmanuel AV, Roy AJ, Nicholls TJ, Kamm MA.

Aliment Pharmacol Ther. 2002 Jul;16(7):1347-56.

11.

Prucalopride: a new drug for the treatment of chronic constipation.

Tack J.

Expert Rev Gastroenterol Hepatol. 2009 Aug;3(4):337-43. doi: 10.1586/egh.09.38. Review.

PMID:
19673621
12.

Efficacy and safety of prucalopride in adults and children with chronic constipation.

Diederen K, Mugie SM, Benninga MA.

Expert Opin Pharmacother. 2015 Feb;16(3):407-16. doi: 10.1517/14656566.2015.996547. Epub 2014 Dec 24. Review.

PMID:
25539475
13.

[Treatment of severe chronic constipation: differential roles of conventional laxatives and the prucalopride prokinetic].

Layer P, Dathe K, Dignass A, Faiss S, Galle P, Lerch MM, Malfertheiner P, Wehrmann T, Zeuzem S.

Z Gastroenterol. 2011 Aug;49(8):969-70. doi: 10.1055/s-0031-1273444. Epub 2011 Jul 27. German. No abstract available.

PMID:
21796580
14.

Prucalopride. In chronic constipation: poorly documented risks.

[No authors listed]

Prescrire Int. 2011 May;20(116):117-20.

PMID:
21648173
15.

Psychometric performance and clinical meaningfulness of the Patient Assessment of Constipation-Quality of Life questionnaire in prucalopride (RESOLOR) trials for chronic constipation.

Dubois D, Gilet H, Viala-Danten M, Tack J.

Neurogastroenterol Motil. 2010 Feb;22(2):e54-63. doi: 10.1111/j.1365-2982.2009.01408.x. Epub 2009 Sep 17.

PMID:
19761492
16.

Effect of prucalopride on intestinal gas tolerance in patients with functional bowel disorders and constipation.

Malagelada C, Nieto A, Mendez S, Accarino A, Santos J, Malagelada JR, Azpiroz F.

J Gastroenterol Hepatol. 2017 Aug;32(8):1457-1462. doi: 10.1111/jgh.13733.

PMID:
28090679
17.

Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation.

Tack J, Corsetti M.

Expert Opin Drug Metab Toxicol. 2012 Oct;8(10):1327-35. doi: 10.1517/17425255.2012.719497. Review.

PMID:
22985444
18.

Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation.

Sloots CE, Poen AC, Kerstens R, Stevens M, De Pauw M, Van Oene JC, Meuwissen SG, Felt-Bersma RJ.

Aliment Pharmacol Ther. 2002 Apr;16(4):759-67.

19.

Randomised clinical trial: macrogol/PEG 3350+electrolytes versus prucalopride in the treatment of chronic constipation -- a comparison in a controlled environment.

Cinca R, Chera D, Gruss HJ, Halphen M.

Aliment Pharmacol Ther. 2013 May;37(9):876-86. doi: 10.1111/apt.12278. Epub 2013 Mar 11.

20.

New pharmacological treatment options for chronic constipation.

Corsetti M, Tack J.

Expert Opin Pharmacother. 2014 May;15(7):927-41. doi: 10.1517/14656566.2014.900543. Epub 2014 Mar 24. Review.

PMID:
24661106

Supplemental Content

Support Center